ISSN 0976 - 8157

www.pharmacie-globale.info

Indexing & Abstracting: DOAJ, Index Copernicus, Chemical Abstract Services (CAS), EBSCO Publishing, Ulrich's Serial database, NewJour, GFMER, Science Central, Libraries Directory, IRNEM, Biblioteca, Open J-gate...........
Home Publication Ethics

Publication Ethics

E-mail Print PDF

Research Ethics

The International Journal of Comprehensive Pharmacy, policies relating to bioethics, such as experiments and research on animals can be found at research and reporting guidelines and Initiatives and must comply with the Declaration of Helsinki and approved by the appropriate ethical committee.

Papers involving such experiments must have to mention the name of the ethics committee and the reference number and supportive information and documents of this should be made available by authors to the editors on request.

Research involving human and animals

Research Reporting Guidelines and Initiatives

AMA Manual of Style
ARRIVE: Animal Research: Reporting of In Vivo Experiments
ASSERT: A Standard for the Scientific and Ethical Review of Trials
CDE: Common Data Elements
CDISC: Clinical Data Interchange Standards Consortium
CONSORT: Consolidated Standards of Reporting Trials
CONSORT Plus
EQUATOR: Enhancing the QUAlity and Transparency Of health Research
MIAME: Minimum Information About a Microarray Experiment
Practihc: Pragmatic Randomized Control Trials in Healthcare
Principles and Guidelines for Reporting Preclinical Research
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
QUOROM: QUality Of Reporting Of Meta-analyses
The REFLECT Statement:Reporting guidElines For randomized controLled trials for livestock and food safety
STARD: STAndards for the Reporting of Diagnostic accuracy
STREGA: STrengthening the REporting of Genetic Associations
STRICTA (REVISED STRICTA): STandards for Reporting Interventions in Controlled Trials of Acupuncture
STROBE: STrengthening the Reporting of OBservational studies in Epidemiology

The International Journal of Comprehensive Pharmacy, aims to ensure that all research including human and animals should as per the standard reporting guidelines and information should be shared among all members involved in technical publishing process of International Journal of Comprehensive Pharmacy.



Consent to participate (Human)

An informed consent must be taken from the human participants in research/experiments involving humans. Children under 16, an informed consent must be signed from parents or legal guardian.

Research involving plants

Experimental research involving plants must comply as per the institutional, national and international guidelines. A voucher specimens must be deposited in institutional or public herbarium with details of submitted voucher specimens along with who identified the specimen must be included in the paper.

Any field study should be in compliance with local legislation and details of license should be stated in the paper.

We recommend author to visit the Convention on International Trade in Endangered Species of Wild Fauna and Flora(CITES)

Publication ethics

Authorship matters

Who is author?

The ICMJE recommends that authorship be based on the following 4 criteria:

• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND

• Drafting the work or revising it critically for important intellectual content; AND

• Final approval of the version to be published; AND

• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

As an author:

The International Journal of Comprehensive Pharmacy requires all the authors of a submitted paper to sign the letter of submission along with a cover letter and authors contribution details to ensure transparency.

Authors of submitted paper are invited to suggest at least three external or independent reviewers; details of suggested independent reviewers will be enclosed or attached as a separate file with detailed information which verify the identity of the reviewer including email id or ORCID.

Intentionally falsifying information about suggested reviewers leads to investigation and rejection of paper.

Responsibility:

Corresponding author is a sole person responsible for managing all communication between the editorial office of the journal before and after publication. In case if published paper has critiques of the work, corresponding author should be available to respond to critiques and cooperate with editorial office for any type of requests for data or any additional information.

Changes or Correction:


Any changes needed like authors listing sequence, addition or deletion of authors before or after the publication will be approved by all authors of the submitted or published paper. Any addition or deletion of authors from published paper needs a written consent letter approved by all authors with valid reason of addition and deletion.

Editorial office expect that the corresponding author is sole responsible person for all journals’ administrative requirements and available throughout the editorial and publication process (Pre and post publication) in a timely manner.

Authorship for large groups:

In large multi author group, the group decides the corresponding author for submission of work to the International Journal of Comprehensive Pharmacy.

All members of the group named as authors should meet all four criteria for authorship, including approval of the final manuscript, and they are responsible for the accuracy and integrity of work.

Some large multi-author groups designate authorship by a group name, with or without the names of individuals. When submitting a manuscript authored by a group, the corresponding author should specify the group name if one exists, and clearly identify the group members who can take credit and responsibility for the work as authors. The byline of the article identifies who is directly responsible for the manuscript, and MEDLINE lists as authors whichever names appear on the byline. If the byline includes a group name, MEDLINE will list the names of individual group members who are authors or who are collaborators, sometimes called non-author contributors, if there is a note associated with the byline clearly stating that the individual names are elsewhere in the paper and whether those names are authors or collaborators.

Confidentiality:

The International Journal of Comprehensive Pharmacy,  editorial office treats all submitted content and communications among authors and editorial board members as confidential and will not be disclosed to the third party. We also expect from authors to treat all communication with editorial office, editors and reviewers as confidential and not to post such communications to public domains or blogs or otherwise publicized without prior permission from the editorial office.

 

Editorial Policies

All the submitted articles must comply in full with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

Submitted articles will be assessed by expert editorial staff (External and in-house) as per accordance to peer review. The submitted articles is first processed by in-house editors followed by transfer to associate editor who has sound knowledge of the areas discussed in the article.

Associate editor decides the articles priority order, importance to the journals’ readership and fulfilment towards journals’ spectrum/scope.

Associate editor will quickly reject the articles, not complying with author guidelines or unable to get high priority order. Articles complying the journal guidelines, scope and priority order are reviewed by minimum two external reviewers with double blind review process.

Information related to editorial decision as to acceptance for submitted article will be provided within 3-5 weeks of submission.

Confidentiality

Editorial staff will maintain confidentiality of the submitted articles. Reviewers involved in review process required to maintain confidentiality of review process and not allowed to discuss article report or process to authors or any third party. Any articles submitted or under correspondence with the International Journal of Comprehensive Pharmacy, confidential content and referees’ report must not be posted in any public domain or any website without prior permission from the editorial office/staff.

Disclosure:

For the submitted article authors are sole responsible for disclosing all financial and personal relationships that might bias their work. Authors have to submit disclosure for any potential conflict of interest associated with submitted article. Individual studies received funds from any source either government, private or commercial firms information should along with or in cover letter.

Conflict of interests (COI):

For COI form and further details, please visit: International Committee of Medical Journal Editors

Piracy is defined as the unauthorized reproduction or use of ideas, data, or methods from others without adequate permission or acknowledgment. Again, deceit plays a central role in this form of misconduct. The intent of the perpetrator is the untruthful portrayal of the ideas or methods as his or her own.

Plagiarism is a form of piracy that involves the unauthorized use or close imitation of the language (figures, images, or tables) and thoughts of others and the representation of them as one’s own original work without permission or acknowledgment by the author of the source of these materials. Plagiarism generally involves the use of materials from others, but can apply to researchers’ duplication of their own previously published reports without acknowledgment (this is sometimes called self-plagiarism or duplicate publication).

Source: Council of Science editors

Policy:

The International Journal of Comprehensive Pharmacy is associated with group of experienced and expert editors from the publication industry who will verify the originality of submitted papers apart from this the papers will scan with the help of the CrossCheck database. Any misconduct ends with initial rejection. In case if any misconduct found after publication of paper in International Journal of Comprehensive Pharmacy, the editorial office will contact author’s affiliated institute and funding agencies with bidirectional statement linked online to and from the original paper and linked to the plagiarised published paper with reference and plagiarized content will be marked.

Plagiarism may also leads to retraction of paper.

Duplicate or overlap publication:

Duplicate (or redundant) publication is the publication of a paper that is substantially similar to a published paper by the same author, without acknowledging the source and without obtaining the permission of the original copyright holder. (Source: ICMJE)

Paper submitted to the International Journal of Comprehensive Pharmacy must be original. Authors should declare any duplicate publications during the time of submission with proper citation of duplicate publications.

The International Journal of Comprehensive Pharmacy reserve rights to judge any duplicate publications.

Retraction and Errata:

Articles may be retracted or withdrawn by their authors, academic or institutional sponsor, editor or publisher, because of pervasive error or unsubstantiated or irreproducible data.

Policy:

Information will be displayed at the journals website stating that article is retracted wholly or partially. Retraction are indexed and linked to the original article (labelled and published in citable form).

Errata:

Errata are published in citable form and notice will appear on a numbered page in a subsequent issue of the journal in which the article was originally published.

International Journal of Comprehensive Pharmacy follows NLM retraction policy.

For more details reading please visit: Errata, Retractions, Partial Retractions, Corrected and Republished Articles, Duplicate Publications, Comments (including Author Replies), Updates, Patient Summaries, and Republished (Reprinted) Articles Policy for MEDLINE.

Reprint:

The International Journal of Comprehensive Pharmacy, occasionally republish (i.e., reprint) and if reprint than cited as “Republished from:” and “Republished. Link will be created between original article and republished article.

Training of Editors

The International Journal of Comprehensive Pharmacy, assigned a managing and a section editor, received an initial training to detect any irregularities. Editorial staff will have time to time updates and training from our outsource partner companies for recent advancements in of publication process and technology.

Internal audit

For proper editorial management International Journal of Comprehensive Pharmacy will carry internal audit from guest editors every two year to detect and prevent any breaches. Internal audit includes random and blind collection of articles and peer review by third party or guest editor.

Complaint policy:

Please registered you complaint at This e-mail address is being protected from spambots. You need JavaScript enabled to view it

The International Journal of Comprehensive Pharmacy author licence and open access policy:

The International Journal of Comprehensive Pharmacy follows open access publishing model.

Open access:

Open access (OA) refers to online research outputs that are free of all restrictions on access (e.g., access tolls) and free of many restrictions on use (e.g. certain copyright and license restrictions). Read more at https://en.wikipedia.org/wiki/Open_access

All open access articles in International Journal of Comprehensive Pharmacy are published under Creative Commons licences. CC BY licence allows unrestricted reuse of the article providing the author(s) and original source are properly cited.

Alternative Creative Commons open access licenses are available on request, please contact the editorial office.

All open access articles associated with Article Processing Charges (APC) and available freely on the International Journal of Comprehensive Pharmacy platform.

Fee waiver policy:

Partial fee waiver for submitted open access articles based on HINARI Countries and will considered on a case-by-case basis. Request for waiver should be made prior or during the article submission; request during the review process or during editing or after acceptance will not be considered.

Benefits of Open access:

1. Freely available to journals audience and readers

2. Increased readership

3. Increased citation with more impact as compared to subscription based

4. Greater world wide collaborative research

Self archiving policy:

After publication of open access article, International Journal of Comprehensive Pharmacy encouraged authors to submit their final author copy to PubMedCentral, institution’s repositories, appropriate funding body’s archive or website.

Article published via hybrid (subscription model), International Journal of Comprehensive Pharmacy encouraged authors to submit author’s version of accepted article to a repository for the audience six months after publication.

Reuse of published content:

Any reuse of International Journal of Comprehensive Pharmacy published content/articles is subjected to permission from editorial office of International Journal of Comprehensive Pharmacy. Achieved content may not be re-used for any commercial purpose or commercial advantage by the means of sale, resale, licence, loan, bulk promotion and other form of commercial promotions.

Any archived content of International Journal of Comprehensive Pharmacy may not be published verbatim in whole or in part, whether or not this is done for Commercial Purposes, either in print or online.

It is the moral responsibility that re-used content should be full attributed as a link of journals website from which content was re-used using article DOI.

International Journal of Comprehensive Pharmacy restricted and applied prohibition for whole sale re-publishing.

 

Last Updated on Thursday, 12 January 2017 09:55  

LATEST NEWS


Editorial Board

Who's Online

We have 15 guests online

Statistics Counter

joomla visitor

Polls

Do you think pharmaceutical companies should spend more on educating physicians about their products?
 

Social Widgets